Skip to content
HeyJared

The Med Matrix Method

Ever wonder why some people feel unstoppable while others struggle with the same health issues? Every week, our functional medicine professionals spill the secrets: Jaw-dropping patient success storiesRoot cause reports your doctor might have missedLife-changing tips &…

Podcast · By Med Matrix USA · American English · US · Official site

Indexed episodes, last 90 days
28
Latest publication
Aug 27, 2026
Audience
Checking…
Earliest in this view
Aug 19, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest episodes

  1. Episode · Aug 27, 2026

    Trailer: Ehlers-Danlos, POTS and Mast Cell Activation Syndrome: They Travel Together (opens the original)

    Episode notes

    Read excerpt

    A short preview of this episode.

  2. Episode · Aug 27, 2026

    Ehlers-Danlos, POTS and Mast Cell Activation Syndrome: They Travel Together (opens the original)

    Episode notes · Critical tone

    Read excerpt

    Ehlers-Danlos syndrome, POTS and mast cell activation syndrome show up in the same patient far more often than chance would explain. That person usually spends years being bounced between specialists. Dr. Sasha Rose and Colin Renaud, PA-C are direct about why: these conditions span multiple systems at once, so they do not fall neatly into cardiology, rheumatology or allergy. Patients get dismissed, see specialist after specialist, and leave each one with a partial answer. Meanwhile they are hype

  3. Episode · Aug 26, 2026

    The Hormone Nobody Tests in Women (opens the original)

    Episode notes

    Read excerpt

    When women talk about hormones, the conversation is estrogen and progesterone. Testosterone gets treated as a sexual health issue and little else. Colin Renaud, PA-C calls that a big misunderstanding, and this episode is about what it costs. Testosterone has a role in muscle, metabolism, bone health, mood, energy and overall vitality in women, and it is routinely left off the panel entirely. Colin walks through what actually gets tested versus what should be, the difference between total and fre

  4. Episode · Aug 26, 2026

    Trailer: The FDA Just Voted on BPC-157. It Was Close. (opens the original)

    Episode notes

    Read excerpt

    A short preview of this episode.

  5. Episode · Aug 26, 2026

    The FDA Just Voted on BPC-157. It Was Close. (opens the original)

    Episode notes

    Read excerpt

    On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted eight to six, with one abstention, to recommend adding BPC-157 to the 503A bulks list. A recommendation, not an approval, and a margin that tells you how divided the room was. Dr. Sasha Rose and Colin Renaud, PA-C walk through what BPC-157 actually is, where the research genuinely sits, and why the gap between how badly people want it and how little human evidence exists is the whole story. They cover what the 503A bulks l

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about The Med Matrix Method